Clostridium difficile-associated disease. Epidemiology, morbidity, mortality, and methods for control

Area of Science:

• Infectious Diseases
• Hospital Epidemiology
• Antimicrobial Stewardship

Background:

• Clostridium difficile-associated disease (CDAD) incidence has risen significantly since the 1970s.
• While CDAD can occur in outpatients, most cases are hospital-acquired (nosocomial).
• CDAD presents with symptoms from mild diarrhea to severe colitis, leading to substantial morbidity, mortality, and healthcare costs.

Purpose of the Study:

• To highlight the increasing challenge of controlling Clostridium difficile transmission in healthcare settings.
• To discuss current strategies for CDAD control, including infection prevention and antibiotic management.

Main Methods:

• Review of infection control measures: patient isolation, hand hygiene, environmental disinfection, barrier precautions.
• Exploration of antibiotic manipulation strategies: reducing overall antibiotic use and selecting lower-risk agents.
• Consideration of biotherapy as a control measure.

Main Results:

• Effective control of CDAD requires a multi-faceted approach.
• Infection control practices are crucial for limiting C. difficile transmission.
• Antibiotic stewardship, including judicious use and selection of less-risky antibiotics (e.g., penicillins over clindamycin, cephalosporins), is a key strategy.

Conclusions:

• Controlling Clostridium difficile-associated disease necessitates comprehensive strategies combining rigorous infection prevention with informed antibiotic stewardship.
• Reducing exposure to high-risk antibiotics is vital in preventing CDAD.
• Healthcare facilities must prioritize multifaceted approaches to mitigate the impact of CDAD.